RFP Entries in Dermatology Therapeutic Area
Competitive Research Grant: How does lebrikizumab impact post-inflammatory dyspigmentation as measured by the PDCA-Derm™ scale in patients with moderate to severe atopic dermatitis?-
Efficacy of Lebrikizumab in patients with fibrosing skin conditions- Competitive Research Grant
